Literature DB >> 6992077

Childhood neutropenia.

R M Weetman, L A Boxer.   

Abstract

Neutropenia can occur because of abnormalities of marrow stem cell development, poor release of polymorphonuclear leukocytes from the marrow reserve, or decreased survival of polymorphonuclear leukocytes. Some of the more important clinical entities are discussed.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6992077     DOI： 10.1016/s0031-3955(16)33856-1

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN： 0031-3955            Impact factor:   3.278


  5 in total

Review 1.  Drug-induced agranulocytosis.

Authors:  H Heimpel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

2.  A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

Authors:  D C Dale; M A Bonilla; M W Davis; A M Nakanishi; W P Hammond; J Kurtzberg; W Wang; A Jakubowski; E Winton; P Lalezari
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

3.  Thickened cortical bones in congenital neutropenia.

Authors:  M I Boechat; L S Gormley; B J O'Laughlin
Journal:  Pediatr Radiol       Date:  1987

4.  The effects of rG-CSF on health-related quality of life in children with congenital agranulocytosis.

Authors:  P D Cleary; G Morrissey; A Yver; G Oster
Journal:  Qual Life Res       Date:  1994-10       Impact factor: 4.147

5.  Idiopathic neutropenia of childhood is associated with Fas/FasL expression.

Authors:  Kari C Nadeau; Angel Callejas; Wendy B Wong; Jae Won Joh; Harvey J Cohen; Michael R Jeng
Journal:  Clin Immunol       Date:  2008-09-26       Impact factor: 3.969
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.